Read a recent article in the Journal of mHealth (Volume 3, Issue 3), McCombie and colleagues
performed a systematic review of IBD symptom monitoring smartphone apps.
Highlight from this Article
In this study, 233 separate apps were found on Google Play Store (Android) and Apple App Store (iPhone) that matched their search criteria for IBD. Out of this inital apps they included 17 apps for an in dept analysis for app store reviews, price, involvement of medical professionals in the development of the apps and the ability to record clincal symptoms. Only four out of the 17 apps were developed with the help of medical professionals and none was tested in a clinical settings in regard of usability and improvement of medical care of IBD patients.
They point out that the inclusion of fecal calprotectin measurement via an home test such as IBDoc® and other similar systems as an objective value would enhance the monitoring apps. In the authors’ view, an integrated solution would be the best approach and studies are needed to show that such an integrated solution can reduce the need for face-to-face outpatient appointments and improve the care of IBD patients over all.
BUHLMANN Diagnostics Corp (BDC), Amherst NH is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assays kits. Located in a state-of-the-art facility in Southern New Hampshire, the BDC team collectively represents over 100 years of experience in serving both clinical and basic science research laboratories.